Patient Guide: An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 34 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06488664
Status: ACTIVE_NOT_RECRUITING
Condition: Plaque Psoriasis
Phase: PHASE3

Where You Can Participate

This study is available at 34 locations across the country.

Top locations include:
  • • Murino, Leningrad region
  • • Korolev, Moscow region
  • • Kazan, Republic of Tatarstan
  • • And 31 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis - Join Clinical Trial NCTNCT06488664

How to Join This Clinical Trial - NCTNCT06488664

Learn how to participate in this PHASE3 trial studying an investigational therapy for Plaque Psoriasis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Plaque Psoriasis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Plaque Psoriasis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06488664 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 34 locations. Find a study site near you:

Clinical Research Site

Murino, Leningrad region 188678 - Russian Federation

Status: Contact for availability

Clinical Research Site

Korolev, Moscow region 141060 - Russian Federation

Status: Contact for availability

Clinical Research Site

Kazan, Republic of Tatarstan 420111 - Russian Federation

Status: Contact for availability

Clinical Research Site

Barnaul, 656038 - Russian Federation

Status: Contact for availability

Clinical Research Site

Chelyabinsk, 454048 - Russian Federation

Status: Contact for availability

Clinical Research Site

Chelyabinsk, 454126 - Russian Federation

Status: Contact for availability

Clinical Research Site

Ekaterinburg, 620076 - Russian Federation

Status: Contact for availability

Clinical Research Site

Izhevsk, 426061 - Russian Federation

Status: Contact for availability

Clinical Research Site

Kirov, 610027 - Russian Federation

Status: Contact for availability

Clinical Research Site

Lipetsk, 398005 - Russian Federation

Status: Contact for availability

And 24 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Plaque Psoriasis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships